MaxCyte
MXCT
114 hedge funds and large institutions have $269M invested in MaxCyte in 2024 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 50 increasing their positions, 38 reducing their positions, and 17 closing their positions.
32% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 38
1.14% more ownership
Funds ownership: 64.22% → 65.37% (+1.1%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
4% less capital invested
Capital invested by funds: $281M → $269M (-$12.3M)
7% less funds holding
Funds holding: 123 → 114 (-9)
43% less call options, than puts
Call options by funds: $8K | Put options by funds: $14K
47% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 17
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$4.82M |
| 2 |
CCM
Cadian Capital Management
New York
|
+$4.57M |
| 3 |
BlackRock
New York
|
+$3.93M |
| 4 |
MA
Mudita Advisors
London,
United Kingdom
|
+$3.06M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$2.15M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
126
Russell Investments Group
London,
United Kingdom
| – | -$28.1K | -6,700 | Closed |
|
|
MLICM
127
Metropolitan Life Insurance Company (MetLife)
New York
| – | -$21.1K | -5,026 | Closed |
|
|
SPIA
128
Steward Partners Investment Advisory
New York
| – | -$6.83K | -1,630 | Closed |
|
|
C
129
Covestor
London,
United Kingdom
| – | -$163 | -38 | -95% |
|
|
AWM
130
Avior Wealth Management
Omaha,
Nebraska
| – | -$71 | -17 | Closed |
|
131
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| – | +$288 | +67 | +1,675% |
|
MXCT Hedge Fund Activity: Q2 2024 in Review
114 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in MaxCyte (MXCT) for Q2 2024, worth a combined $269M — down 4.4% from $281M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of MXCT and 9 opened new positions — a net loss of 8 holders — while 38 trimmed existing stakes and 50 added.
The largest buyer was Morgan Stanley, adding an estimated $4.82M. The largest seller was Massachusetts Financial Services, cutting an estimated $8.71M.
- 114 institutional investors held MaxCyte (MXCT) as of Q2 2024, down from 123 in Q1 2024.
- Funds reported $269M of MaxCyte stock for Q2 2024, down 4.4% quarter-over-quarter.
- 9 funds opened new MaxCyte positions in Q2 2024 and 17 closed out, a net change of -8 holders.
- The largest MaxCyte buyer in Q2 2024 was Morgan Stanley, an estimated $4.82M added.
- The largest MaxCyte seller in Q2 2024 was Massachusetts Financial Services, an estimated $8.71M sold.
Based on aggregated 13F filings for Q2 2024.